| 3001 |
Apheresis |
Allogeneic |
Beta Thalassemia Major |
Hematology |
2022 |
Standard Therapy |
Poland |
11 |
| 3002 |
Apheresis |
Allogeneic |
C-All Rez (Acute Lymphoblastic Leukemia) |
Hematology |
2022 |
Standard Therapy |
Poland |
66 |
| 3003 |
Apheresis |
Allogeneic |
C-All Rez (Acute Lymphoblastic Leukemia) |
Hematology |
2022 |
Standard Therapy |
Poland |
5 |
| 3004 |
Apheresis |
Allogeneic |
Chronic Granulomatous Disease |
Hematology |
2022 |
Standard Therapy |
Poland |
3 |
| 3005 |
Apheresis |
Allogeneic |
Chronic Granulomatous Disease |
Hematology |
2022 |
Standard Therapy |
Poland |
3 |
| 3006 |
Apheresis |
Allogeneic |
Chronic Granulomatous Disease |
Hematology |
2022 |
Standard Therapy |
Poland |
5 |
| 3007 |
Apheresis |
Allogeneic |
Chronic Lymphocytic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
63 |
| 3008 |
Apheresis |
Allogeneic |
Chronic Lymphocytic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
59 |
| 3009 |
Apheresis |
Allogeneic |
Chronic Lymphocytic Leukemia |
Hematology |
2022 |
Standard Therapy |
Germany |
58 |
| 3010 |
Apheresis |
Allogeneic |
Chronic Lymphocytic Leukemia Richter Transformation 7/22 |
Hematology |
2022 |
Standard Therapy |
Poland |
44 |
| 3011 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
64 |
| 3012 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
67 |
| 3013 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
63 |
| 3014 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
59 |
| 3015 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
64 |
| 3016 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
60 |
| 3017 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
70 |
| 3018 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
54 |
| 3019 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
63 |
| 3020 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
54 |
| 3021 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
71 |
| 3022 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
67 |
| 3023 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia, Type 0 (Cmml-0) |
Hematology |
2022 |
Standard Therapy |
Poland |
64 |
| 3024 |
Apheresis |
Allogeneic |
Chronic Neutrophilic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
66 |
| 3025 |
Apheresis |
Allogeneic |
Chronic Neutrophilic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
72 |
| 3026 |
Apheresis |
Allogeneic |
Combined Immunodeficiency Syndrome With Hyper-Igm |
Hematology |
2022 |
Standard Therapy |
Poland |
6 |
| 3027 |
Apheresis |
Allogeneic |
Congenital Dyserythropoietic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
2 |
| 3028 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma |
Hematology |
2022 |
Standard Therapy |
Germany |
68 |
| 3029 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma |
Hematology |
2022 |
Standard Therapy |
Germany |
65 |
| 3030 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma |
Hematology |
2022 |
Standard Therapy |
Germany |
69 |
| 3031 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma |
Hematology |
2022 |
Standard Therapy |
Germany |
50 |
| 3032 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma |
Hematology |
2022 |
Standard Therapy |
Germany |
56 |
| 3033 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma |
Hematology |
2022 |
Standard Therapy |
Germany |
65 |
| 3034 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma |
Hematology |
2022 |
Standard Therapy |
Germany |
47 |
| 3035 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma – Relapse |
Hematology |
2022 |
Standard Therapy |
Germany |
66 |
| 3036 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma With Cerebral Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Germany |
66 |
| 3037 |
Apheresis |
Autologous |
Germ Cell Tumor |
Hematology |
2022 |
Standard Therapy |
Germany |
39 |
| 3038 |
Apheresis |
Autologous |
Germ Cell Tumor |
Hematology |
2022 |
Standard Therapy |
Germany |
33 |
| 3039 |
Apheresis |
Allogeneic |
Hemophagocytic Lymphohistiocytosis (Hlh) |
Hematology |
2022 |
Standard Therapy |
Poland |
12 |
| 3040 |
Apheresis |
Allogeneic |
Hemophagocytic Lymphohistiocytosis (Hlh) |
Hematology |
2022 |
Standard Therapy |
Poland |
21 |
| 3041 |
Apheresis |
Allogeneic |
Hodgkin Lymphoma |
Hematology |
2022 |
Standard Therapy |
Poland |
26 |
| 3042 |
Apheresis |
Allogeneic |
Hodgkin Lymphoma |
Hematology |
2022 |
Standard Therapy |
Poland |
31 |
| 3043 |
Apheresis |
Allogeneic |
Hodgkin Lymphoma |
Hematology |
2022 |
Standard Therapy |
Poland |
53 |
| 3044 |
Apheresis |
Allogeneic |
Hodgkin Lymphoma |
Hematology |
2022 |
Standard Therapy |
Poland |
25 |
| 3045 |
Apheresis |
Autologous |
Hodgkin Lymphoma |
Hematology |
2022 |
Standard Therapy |
Germany |
67 |
| 3046 |
Apheresis |
Autologous |
Hodgkin Lymphoma-Relapse |
Hematology |
2022 |
Standard Therapy |
Germany |
69 |
| 3047 |
Apheresis |
Autologous |
Hodgkin Lymphoma-Relapse |
Hematology |
2022 |
Standard Therapy |
Germany |
48 |
| 3048 |
Apheresis |
Allogeneic |
Hypoplastic Myelodysplastic Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
26 |
| 3049 |
Apheresis |
Allogeneic |
Immunodeficiency |
Hematology |
2022 |
Standard Therapy |
Poland |
3 |
| 3050 |
Apheresis |
Allogeneic |
Juvenile Myelomonocytic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
5 |
| 3051 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2022 |
Standard Therapy |
Germany |
64 |
| 3052 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2022 |
Standard Therapy |
Germany |
61 |
| 3053 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2022 |
Standard Therapy |
Germany |
52 |
| 3054 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2022 |
Standard Therapy |
Germany |
44 |
| 3055 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2022 |
Standard Therapy |
Germany |
53 |
| 3056 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2022 |
Standard Therapy |
Germany |
49 |
| 3057 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2022 |
Standard Therapy |
Germany |
64 |
| 3058 |
Apheresis |
Allogeneic |
Mixed Phenotype Acute Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
64 |
| 3059 |
Apheresis |
Autologous |
Morbus Hodgkin |
Hematology |
2022 |
Standard Therapy |
Germany |
36 |
| 3060 |
Apheresis |
Autologous |
Morbus Hodgkin |
Hematology |
2022 |
Standard Therapy |
Germany |
62 |
| 3061 |
Apheresis |
Autologous |
Morbus Hodgkin-Relapse |
Hematology |
2022 |
Standard Therapy |
Germany |
63 |
| 3062 |
Apheresis |
Allogeneic |
Mucopolysaccharidosis |
Hematology |
2022 |
Standard Therapy |
Poland |
2 |
| 3063 |
Apheresis |
Allogeneic |
Mucopolysaccharidosis Type I |
Hematology |
2022 |
Standard Therapy |
Poland |
3 |
| 3064 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2022 |
Standard Therapy |
Germany |
58 |
| 3065 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2022 |
Standard Therapy |
Germany |
53 |
| 3066 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2022 |
Standard Therapy |
Germany |
57 |
| 3067 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2022 |
Standard Therapy |
Germany |
64 |
| 3068 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2022 |
Standard Therapy |
Germany |
50 |
| 3069 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2022 |
Standard Therapy |
Germany |
67 |
| 3070 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2022 |
Standard Therapy |
Germany |
55 |
| 3071 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2022 |
Standard Therapy |
Germany |
73 |
| 3072 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2022 |
Standard Therapy |
Germany |
63 |
| 3073 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2022 |
Standard Therapy |
Germany |
65 |
| 3074 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2022 |
Standard Therapy |
Germany |
58 |
| 3075 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2022 |
Standard Therapy |
Germany |
37 |
| 3076 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2022 |
Standard Therapy |
Germany |
47 |
| 3077 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2022 |
Standard Therapy |
Germany |
68 |
| 3078 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2022 |
Standard Therapy |
Germany |
53 |
| 3079 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2022 |
Standard Therapy |
Germany |
60 |
| 3080 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2022 |
Standard Therapy |
Germany |
60 |
| 3081 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2022 |
Standard Therapy |
Germany |
47 |
| 3082 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2022 |
Standard Therapy |
Germany |
59 |
| 3083 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2022 |
Standard Therapy |
Germany |
64 |
| 3084 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2022 |
Standard Therapy |
Germany |
59 |
| 3085 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2022 |
Standard Therapy |
Germany |
52 |
| 3086 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2022 |
Standard Therapy |
Germany |
73 |
| 3087 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2022 |
Standard Therapy |
Germany |
68 |
| 3088 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2022 |
Standard Therapy |
Germany |
63 |
| 3089 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2022 |
Standard Therapy |
Germany |
66 |
| 3090 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2022 |
Standard Therapy |
Germany |
50 |
| 3091 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2022 |
Standard Therapy |
Germany |
69 |
| 3092 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2022 |
Standard Therapy |
Germany |
57 |
| 3093 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2022 |
Standard Therapy |
Germany |
55 |
| 3094 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2022 |
Standard Therapy |
Germany |
61 |
| 3095 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2022 |
Standard Therapy |
Germany |
64 |
| 3096 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2022 |
Standard Therapy |
Germany |
71 |
| 3097 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2022 |
Standard Therapy |
Germany |
61 |
| 3098 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2022 |
Standard Therapy |
Germany |
62 |
| 3099 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2022 |
Standard Therapy |
Germany |
60 |
| 3100 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2022 |
Standard Therapy |
Germany |
33 |